
Researchers from Vanderbilt University Medical Center determine the metabolic pathway that S aureus uses to survive in bones.
Researchers from Vanderbilt University Medical Center determine the metabolic pathway that S aureus uses to survive in bones.
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
A prospective examination of over 2600 patients has not revealed a difference in their outcome compared with patients who are non-neutropenic when it comes to bacteremia caused by Staphylococcus aureus.
The opening session of ASM Microbe 2018 cuts a broad swath through the science of microbiology.
What makes a germ more likely to cause a pandemic? A new report poses a novel framework for addressing this question.
McGill University researchers find that infection with C difficile might more likely be linked to infected than colonized donors.
A lack of coordination among regulating bodies, pharma manufacturers, standard development organizations, and laboratory testing device companies has muddied efforts to stop antibiotic resistance; the 21st Century Cures Act aims to fix that.
The FDA has granted Orphan Drug Designation to Chimerix’s brincidofovir for the treatment of smallpox.
As the outbreak claims more lives, the FDA performs extensive traceback efforts to identify a primary source.
The therapy, used to treat and prevent bloodstream infections and related complications in patients who have central venous catheters, has been found to be ineffective in pediatric cancer patients.
The overall rate of health care personnel receiving flu shots has gone up in recent years, but a new study finds that much of the increase is due to policies held at non-VA hospitals.
Much about the virus and the proper public health response to outbreaks remains up for debate.
The FDA has approved Lannet Company’s Abbreviated New Drug Application for levofloxacin oral solution USP, 25 mg/mL.
A higher number of new sexual partners, as well as lifetime sexual partners, may drive this risk in these patients.
A new study looks at the process by which A. fumigatus crosses the airway epithelium, positing a theory involving the use of actin to tunnel into cells.
Could dressing more formally induce patients to adhere to their treatment plans?
Fulphila is the first biosimilar to Neulasta to decrease the chance of infection in patients with non-myeloid cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.
The results of a new study reveal that rates of viral suppression in women infected with HIV have improved since 2001; however, control of diabetes mellitus has remained poor, regardless of HIV status.
A recent study has shown that highly pathogenic avian influenza (HPAI) A(H7N9) virus is spreading westward from southern and eastern China.
Although the incidence of nontuberculous mycobacterial (NTM) lung disease is increasing, and current treatment options are limited, certain NTM patients may find a potential treatment option in video-assisted thoracoscopic surgery.
In case you missed them, we’ve compiled a list of the latest recalls posted this week.
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
All endoscopic procedures held a greater risk of postprocedure infection than screening mammography; however, they were still lower risk than bronchoscopy and cystoscopy.
The new guidelines include updates on HCV management and testing in pregnant women, individuals who inject drugs, men who have sex with men, and individuals who are incarcerated.
Tennessee joins the list of states currently being plagued by hepatitis A outbreaks.
The Vaccine Adverse Event Reporting System reveals a number of errors made in the administration of the new shingles vaccine.
A new study has found that travelers’ diarrhea from Escherichia coli infection may be more likely to occur in individuals with blood type A.
The 5-year partnership grant is to support the development of novel immunotherapy agents that target multidrug-resistant Gram-negative bacterial infections.
Although most health care providers are adhering to the recommended regimen, the US Centers for Disease Control and Prevention reports that about 20% of patients with uncomplicated gonorrhea are not receiving the recommended dual regimen designed to ward off resistance.
Stopping polio transmission will require addressing persistent challenges to vaccinating every child.